香丹针和黄芪针治疗病毒性肝炎的前瞻性研究

目的：探讨香丹针和黄芪针治疗病毒性肝炎的临床疗效。方法：将我院收治的177例病毒性肝炎患者随机分为对照组（88例）和观察组（89例），前者采用拉米夫定治疗，后者采用香丹针联合黄芪针治疗。结果：观察组的丙氨酸氨基转移酶（ALT）、血清总胆红素（TB）、凝血酶原时间（PT）与对照组比较，皆优于对照组（P〈0．01）。观察组不良反应发生率显著低于对照纽（P〈0．01）。结论：香丹针和黄芪针治疗病毒性肝炎可以取得很好的治疗效果，值得在临床上进行推广应用。

Prospective study on treating viral hepatitis by Xiangdan injection and Huangqi injection

Objective： To investigate clinical efficacy of Xiangdan injection and Huangqi injection on viral hepatitis. Methods： 177 viral hepatitis patients were randomly divided into two groups, the control （88）, and the treated （89）. In the control lamivudine was given; In the treated Xiangdan injection and Huangqi injection were given. Results： The Alanine aminotransferase （ALT）, serum total bilinlbin （TB） and prothrombin time （PT） in the treated were better than the control （P〈0.01）. Incidence of adverse reactions were lower than that the control （P〈0.01）. Conclusion： Xiangdan injection and Huangqi injection had a significant efficacy in treating viral hepatitis, worthy of a wide clinical application.